Endotoxin Testing Market is estimated to be US$ 2190.52 Million by 2030 with a CAGR of 11.2% during

Nehashaikh07 Jun, 2022News

Global Endotoxin Testing Market accounted for US$ 767.1 million in 2020 and is estimated to be US$ 2190.52 million by 2030 and is anticipated to register a CAGR of 11.2%. The most sensitive and specific approach for detecting endotoxins is limulus amebocyte lysate (LAL). In the pharmaceutical and biomedical industries, bacterial endotoxin testing (BET) is a critical safety criterion. When bacterial endotoxins reach high enough concentrations in the bloodstream, they can induce unpleasant symptoms including fever and septic shock, and in the most severe cases, they can be lethal. As a result, every pharmaceutical product that may enter the body, such as parenteral medicines and injectable devices, must be tested for endotoxins prior to being released to the market.